您好,欢迎来到试剂仪器网! [登录] [免费注册]
试剂仪器网
位置:首页 > 产品库 > FDI-6
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
FDI-6
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
FDI-6图片
CAS NO:313380-27-7
规格:98%
分子量:437.43
包装与价格:
包装价格(元)
5mg电议
10mg电议
25mg电议

产品介绍
FDI-6是一种FOXM1抑制剂。作用于MCF-7乳腺癌细胞中,FDI-6直接与FOXM1蛋白结合,从靶基因组中取代FOXM1,并诱导随后的转录下调。
CAS:313380-27-7
分子式:C19H11F4N3OS2
分子量:437.43
纯度:98%
存储:Store at -20°C

Background:

FDI-6 is an inhibitor of FOXM1. FDI-6 binds directly to FOXM1 protein, to displace FOXM1 from genomic targets in MCF-7 breast cancer cells, and induce concomitant transcriptional down-regulation.


FDI-6 is characterized in depth and is shown to bind directly to FOXM1 protein, to displace FOXM1 from genomic targets in MCF-7 breast cancer cells, and induce concomitant transcriptional down-regulation. MDA-MB-231 ER-negative breast and PEO-1 ovarian cancer cells are sensitive to FDI-6 in cell viability assays (GI50=21.8 μM and 18.1 μM, respectively) and exhibit comparable down-regulation of CDC25B after a 3 h treatment with FDI-6. The transcription factor FOXM1 regulates a network of proliferation-associated genes critical to mitotic spindle assembly, chromosome segregation, and G2/M transition, with depletion leading to cell cycle arrest. Importantly, aberrant up-regulation of FOXM1 has been shown to be a key driver of cancer progression and has been proposed as an initiating factor of oncogenesis[1].



[1]. Gormally MV, et al. Suppression of the FOXM1 transcriptional programme via novel small molecule inhibition. Nat Commun. 2014 Nov 12;5:5165.